Autolus Therapeutics Announces Changes to its Board of Directors Autolus Therapeutics Announces Changes to its Board of Directors

Autolus Therapeutics announces the appointment of John H. Johnson as non-executive chairman of its Board of Directors LONDON, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...